Michael Ferraresso - 10 Aug 2021 Form 4 Insider Report for AVEO PHARMACEUTICALS, INC.

Role
Chief Commercial Officer
Signature
/s/ Michael Ferraresso
Issuer symbol
N/A
Transactions as of
10 Aug 2021
Net transactions value
+$14,996
Form type
4
Filing time
11 Aug 2021, 19:49:17 UTC
Previous filing
13 May 2022
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVEO Common Stock Purchase $14,996 +2,608 +46% $5.75 8,318 10 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,426 shares acquired under AVEO's 2010 Employee Stock Purchase Plan.